Bill Text: NY A08683 | 2017-2018 | General Assembly | Amended


Bill Title: Provides that policies and contracts covering diagnostic screening for prostate cancer shall not be subject to cost sharing; requires notice of availability of such coverage without cost sharing to be provided in the notice to persons at risk of or having prostate cancer.

Spectrum: Slight Partisan Bill (Democrat 2-1)

Status: (Introduced - Dead) 2018-06-19 - substituted by s6882a [A08683 Detail]

Download: New_York-2017-A08683-Amended.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                         8683--A
                               2017-2018 Regular Sessions
                   IN ASSEMBLY
                                   September 25, 2017
                                       ___________
        Introduced by M. of A. GOTTFRIED, GALEF -- read once and referred to the
          Committee on Insurance -- recommitted to the Committee on Insurance in
          accordance  with Assembly Rule 3, sec. 2 -- committee discharged, bill
          amended, ordered reprinted as amended and recommitted to said  commit-
          tee
        AN ACT to amend the public health law, in relation to the written summa-
          ry  relating  to  prostate  cancer; and to amend the insurance law, in
          relation to coverage of diagnostic screening for prostate cancer
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
     1    Section  1. Section 2404-a of the public health law, as added by chap-
     2  ter 141 of the laws of 1997, is amended to read as follows:
     3    § 2404-a. Prostate cancer; duty to inform. 1. The  commissioner  shall
     4  develop a standardized written summary, in plain non-technical language,
     5  which shall explain the following:
     6    (a) the symptoms and risk factors for prostate cancer;
     7    (b)  the available methods for the detection and diagnosis of prostate
     8  cancer, including information on the relative accuracy of the  available
     9  detection and diagnostic techniques;
    10    (c)  the  availability  of insurance coverage for diagnostic screening
    11  for prostate cancer without cost sharing pursuant to subparagraph (B) of
    12  paragraph eleven-a of subsection  (i)  of  section  three  thousand  two
    13  hundred  sixteen,  subparagraph  (B) of paragraph eleven-a of subsection
    14  (1) of section three thousand two hundred twenty-one and  paragraph  two
    15  of  subsection (z-1) of section four thousand three hundred three of the
    16  insurance law; and
    17    [(c)]  (d)  the  alternative  medically  viable  methods  of  treating
    18  prostate  cancer,  including  but not limited to hormonal, radiological,
    19  chemotherapeutic or surgical treatments, or  combinations  thereof.  The
    20  summary  shall  contain information on prostate post-treatment risks and
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13496-03-8

        A. 8683--A                          2
     1  other pertinent information to aid a person  in  deciding  a  course  of
     2  treatment. The summary shall be updated as is necessary.
     3    [(d)]  2. The summary shall be provided to any health care provider or
     4  practitioner providing medical treatment to adult men without charge  or
     5  fee  for distribution in accordance with subdivision [two] three of this
     6  section.
     7    [2.] 3. The standardized written summary provided for  by  subdivision
     8  one  of  this  section may be provided by a health care provider to each
     9  person under [his/her] his or her care who is or  may  be  at  risk  for
    10  prostate  cancer or who has been diagnosed to be afflicted with prostate
    11  cancer upon said diagnosis, or as soon thereafter as practicable.
    12    [3.] 4. Nothing in this section shall be construed to create  a  cause
    13  of  action  for  lack  of informed consent in any instance in which such
    14  cause of action would be limited by section twenty-eight hundred  five-d
    15  of this chapter.
    16    [4.]  5.  The commissioner shall have the written summary, required by
    17  this section, completed and prepared for distribution on or before Janu-
    18  ary first, nineteen hundred ninety-eight.
    19    § 2. Subparagraph (B) of paragraph 11-a of subsection (i)  of  section
    20  3216  of the insurance law, as added by chapter 601 of the laws of 2000,
    21  is amended to read as follows:
    22    (B) Such coverage [may] shall not be  subject  to  annual  deductibles
    23  [and] or coinsurance [as may be deemed appropriate by the superintendent
    24  and as are consistent with those established for other benefits within a
    25  given policy].
    26    §  3.  Subparagraph (B) of paragraph 11-a of subsection (1) of section
    27  3221 of the insurance law, as added by chapter 601 of the laws of  2000,
    28  is amended to read as follows:
    29    (B)  Such  coverage  [may]  shall not be subject to annual deductibles
    30  [and] or coinsurance [as may be deemed appropriate by the superintendent
    31  and as are consistent with those established for other benefits within a
    32  given policy].
    33    § 4. Paragraph 2 of subsection (z-1) of section 4303 of the  insurance
    34  law,  as added by chapter 601 of the laws of 2000, is amended to read as
    35  follows:
    36    (2) Such coverage [may] shall not be  subject  to  annual  deductibles
    37  [and] or coinsurance [as may be deemed appropriate by the superintendent
    38  and as are consistent with those established for other benefits within a
    39  given policy].
    40    §  5.  This act shall take effect immediately, and sections two, three
    41  and four of this act shall apply to all policies and  contracts  issued,
    42  renewed, modified or amended on or after January 1, 2019.
feedback